2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells

Seminars in Cell and Developmental Biology

Volumn 24, Issue 4, 2013, Pages 370-379

  Zasadil, Lauren M ^a,b   Britigan, Eric M C ^a,b   Weaver, Beth A ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Aneuploidy; Chromosomal instability; Polyploidy

Indexed keywords

ANAPHASE PROMOTING COMPLEX; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ENHANCED GREEN FLUORESCENT PROTEIN; PROTEIN P53;

ANAPHASE; ANEUPLOIDY; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CELL ADHESION; CELL CYCLE CHECKPOINT; CELL DEATH; CELL FUNCTION; CELL PROLIFERATION; CELL STRUCTURE; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENE REPRESSION; HUMAN; KARYOTYPING; LETHALITY; MAMMAL CELL; MITOSIS; MITOSIS INDEX; MITOSIS SPINDLE; NEOPLASM; NONHUMAN; POLYPLOIDY; PRIMARY TUMOR; PROGENY; REVIEW; SEX CHROMOSOME; SKIN FIBROBLAST; SOMATIC CELL; TREATMENT RESPONSE; TUMOR CELL;

EID: 84876713816     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2013.02.001     Document Type: Review

References (95)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Cancer incidence and mortality worldwide. IARC CancerBase No 10. Lyon, France: GLOBOCAN; 2008.
2. Boveri T. Zur Frage der Entstehung maligner Tumoren. Jena: Gustav Fischer; 1914 [English translation The Origin of Malignant Tumors by Boveri M. Baltimore: Williams and Wilkins; 1929].
3. Duesberg P., Rausch C., Rasnick D., Hehlmann R. Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:13692-13697.
4. Mayer V.W., Aguilera A. High levels of chromosome instability in polyploids of Saccharomyces cerevisiae. Mutation Research 1990, 231:177-186.
5. Sheltzer J.M., Blank H.M., Pfau S.J., Tange Y., George B.M., Humpton T.J., et al. Aneuploidy drives genomic instability in yeast. Science 2011, 333:1026-1030.
6. Pavelka N., Rancati G., Zhu J., Bradford W.D., Saraf A., Florens L., et al. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature 2010, 468:321-325.
7. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instability in colorectal cancers. Nature 1997, 386:623-627.
8. Kops G.J., Weaver B.A., Cleveland D.W. On the road to cancer: aneuploidy and the mitotic checkpoint. Nature Reviews Caner 2005, 5:773-785.
9. Babu J.R., Jeganathan K.B., Baker D.J., Wu X., Kang-Decker N., van Deursen J.M. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. Journal of Cell Biology 2003, 160:341-353.
10. Baker D.J., Jeganathan K.B., Cameron J.D., Thompson M., Juneja S., Kopecka A., et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature Genetics 2004, 36:744-749.
11. Jeganathan K., Malureanu L., Baker D.J., Abraham S.C., van Deursen J.M. Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. Journal of Cell Biology 2007, 179:255-267.
12. Malureanu L., Jeganathan K.B., Jin F., Baker D.J., van Ree J.H., Gullon O., et al. Cdc20 hypomorphic mice fail to counteract de novo synthesis of cyclin B1 in mitosis. Journal of Cell Biology 2010, 191:313-329.
13. Iwanaga Y., Kasai T., Kibler K., Jeang K.T. Characterization of regions in hsMAD1 needed for binding hsMAD2. A polymorphic change in an hsMAD1 leucine zipper affects MAD1-MAD2 interaction and spindle checkpoint function. Journal of Biological Chemistry 2002, 277:31005-31013.
14. Michel L., Diaz-Rodriguez E., Narayan G., Hernando E., Murty V.V., Benezra R. Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:4459-4464.
15. Kops G.J., Foltz D.R., Cleveland D.W. Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:8699-8704.
16. Thompson S.L., Compton D.A. Chromosome missegregation in human cells arises through specific types of kinetochore-microtubule attachment errors. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:17974-17978.
17. Bakhoum S.F., Thompson S.L., Manning A.L., Compton D.A. Genome stability is ensured by temporal control of kinetochore-microtubule dynamics. Nature Cell Biology 2009, 11:27-35.
18. Ganem N.J., Godinho S.A., Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature 2009, 460:278-282.
19. Janssen A., van der Burg M., Szuhai K., Kops G.J., Medema R.H. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 2011, 333:1895-1898.
20. Crasta K., Ganem N.J., Dagher R., Lantermann A.B., Ivanova E.V., Pan Y., et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 2012, 482:53-58.
21. Gascoigne K.E., Taylor S.S. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 2008, 14:111-122.
22. Thompson S.L., Compton D.A. Examining the link between chromosomal instability and aneuploidy in human cells. Journal of Cell Biology 2008, 180:665-672.
23. Bakhoum S.F., Danilova O.V., Kaur P., Levy N.B., Compton D.A. Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma. Clinical Cancer Research 2011, 17:7704-7711.
24. Ryan S.D., Britigan E.M., Zasadil L.M., Witte K., Audhya A., Roopra A., et al. Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:E2205-E2214.
25. Torres E.M., Sokolsky T., Tucker C.M., Chan L.Y., Boselli M., Dunham M.J., et al. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 2007, 317:916-924.
26. Williams B.R., Prabhu V.R., Hunter K.E., Glazier C.M., Whittaker C.A., Housman D.E., et al. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 2008, 322:703-709.
27. Segal D.J., McCoy E.E. Studies on Down's syndrome in tissue culture. I. Growth rates and protein contents of fibroblast cultures. Journal of Cellular Physiology 1974, 83:85-90.
28. Van Gameren-Oosterom H.B., Van Dommelen P., Oudesluys-Murphy A.M., Buitendijk S.E., Van Buuren S., Van Wouwe J.P. Healthy growth in children with Down syndrome. PLoS ONE 2012, 7:e31079.
29. Rao C.V., Yang Y.M., Swamy M.V., Liu T., Fang Y., Mahmood R., et al. Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:4365-4370.
30. Baker D.J., Jeganathan K.B., Malureanu L., Perez-Terzic C., Terzic A., van Deursen J.M. Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. Journal of Cell Biology 2006, 172:529-540.
31. Weaver B.A., Silk A.D., Montagna C., Verdier-Pinard P., Cleveland D.W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 2007, 11:25-36.
32. van Ree J.H., Jeganathan K.B., Malureanu L., van Deursen J.M. Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation. Journal of Cell Biology 2010, 188:83-100.
33. Thompson S.L., Compton D.A. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. Journal of Cell Biology 2010, 188:369-381.
34. Shen S.X., Weaver Z., Xu X., Li C., Weinstein M., Chen L., et al. A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 1998, 17:3115-3124.
35. Michel L.S., Liberal V., Chatterjee A., Kirchwegger R., Pasche B., Gerald W., et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 2001, 409:355-359.
36. Kaushal D., Contos J.J., Treuner K., Yang A.H., Kingsbury M.A., Rehen S.K., et al. Alteration of gene expression by chromosome loss in the postnatal mouse brain. Journal of Neuroscience 2003, 23:5599-5606.
37. Ricke R.M., Jeganathan K.B., van Deursen J.M. Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation. Journal of Cell Biology 2011, 193:1049-1064.
38. Li M., Fang X., Wei Z., York J.P., Zhang P. Loss of spindle assembly checkpoint-mediated inhibition of Cdc20 promotes tumorigenesis in mice. Journal of Cell Biology 2009, 185:983-994.
39. Macklon N.S., Geraedts J.P., Fauser B.C. Conception to ongoing pregnancy: the 'black box' of early pregnancy loss. Human Reproduction Update 2002, 8:333-343.
40. Plachot M. Chromosomal abnormalities in oocytes. Molecular and Cellular Endocrinology 2001, 183(Suppl. 1):S59-S63.
41. Rehen S.K., McConnell M.J., Kaushal D., Kingsbury M.A., Yang A.H., Chun J. Chromosomal variation in neurons of the developing and adult mammalian nervous system. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:13361-13366.
42. Kingsbury M.A., Friedman B., McConnell M.J., Rehen S.K., Yang A.H., Kaushal D., et al. Aneuploid neurons are functionally active and integrated into brain circuitry. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:6143-6147.
43. Jacobs P.A., Brunton M., Court Brown W.M., Doll R., Goldstein H. Change of human chromosome count distribution with age: evidence for a sex differences. Nature 1963, 197:1080-1081.
44. Nowinski G.P., Van Dyke D.L., Tilley B.C., Jacobsen G., Babu V.R., Worsham M.J., et al. The frequency of aneuploidy in cultured lymphocytes is correlated with age and gender but not with reproductive history. American Journal of Human Genetics 1990, 46:1101-1111.
45. Duncan A.W., Hanlon Newell A.E., Smith L., Wilson E.M., Olson S.B., Thayer M.J., et al. Frequent aneuploidy among normal human hepatocytes. Gastroenterology 2012, 142:25-28.
46. Rehen S.K., Yung Y.C., McCreight M.P., Kaushal D., Yang A.H., Almeida B.S., et al. Constitutional aneuploidy in the normal human brain. Journal of Neuroscience 2005, 25:2176-2180.
47. Baker D.J., Jin F., Jeganathan K.B., van Deursen J.M. Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 2009, 16:475-486.
48. Li M., Fang X., Baker D.J., Guo L., Gao X., Wei Z., et al. The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:14188-14193.
49. Mukherjee M., Ge G., Zhang N., Huang E., Nakamura L.V., Minor M., et al. Separase loss of function cooperates with the loss of p53 in the initiation and progression of T- and B-cell lymphoma, leukemia and aneuploidy in mice. PLoS ONE 2011, 6:e22167.
50. Chi Y.H., Ward J.M., Cheng L.I., Yasunaga J., Jeang K.T. Spindle assembly checkpoint and p53 deficiencies cooperate for tumorigenesis in mice. International Journal of Cancer 2009, 124:1483-1489.
51. Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations and gene fusions in cancer.; 2010. http://cgapncinihgov/Chromosomes/Mitelman.
52. Habermann J.K., Doering J., Hautaniemi S., Roblick U.J., Bündgen N.K., Nicorici D., et al. The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome. International Journal of Cancer 2009, 124:1552-1564.
53. Choi C.M., Seo K.W., Jang S.J., Oh Y.M., Shim T.S., Kim W.S., et al. Chromosomal instability is a risk factor for poor prognosis of adenocarcinoma of the lung: fluorescence in situ hybridization analysis of paraffin-embedded tissue from Korean patients. Lung Cancer 2009, 64:66-70.
54. Kronenwett U., Ploner A., Zetterberg A., Bergh J., Hall P., Auer G., et al. Genomic instability and prognosis in breast carcinomas. Cancer Epidemiology, Biomarkers and Prevention 2006, 15:1630-1635.
55. Roschke A.V., Stover K., Tonon G., Schäffer A.A., Kirsch I.R. Stable karyotypes in epithelial cancer cell lines despite high rates of ongoing structural and numerical chromosomal instability. Neoplasia 2002, 4:19-31.
56. Niikura Y., Dixit A., Scott R., Perkins G., Kitagawa K. BUB1 mediation of caspase-independent mitotic death determines cell fate. Journal of Cell Biology 2007, 178:283-296.
57. Niikura Y., Ogi H., Kikuchi K., Kitagawa K. BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD). Cell Death and Differentiation 2010, 17:1011-1024.
58. Fang Y., Liu T., Wang X., Yang Y.M., Deng H., Kunicki J., et al. BubR1 is involved in regulation of DNA damage responses. Oncogene 2006.
59. Yang C., Wang H., Xu Y., Brinkman K.L., Ishiyama H., Wong S.T., et al. The kinetochore protein Bub1 participates in the DNA damage response. DNA Repair (Amsterdam) 2012, 11:185-191.
60. Myung K., Smith S., Kolodner R.D. Mitotic checkpoint function in the formation of gross chromosomal rearrangements in Saccharomyces cerevisiae. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15980-15985.
61. Ricke R.M., Jeganathan K.B., Malureanu L., Harrison A.M., van Deursen J.M. Bub1 kinase activity drives error correction and mitotic checkpoint control but not tumor suppression. Journal of Cell Biology 2012, 199:931-949.
62. Cowley D.O., Muse G.W., Van Dyke T. A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic background. Molecular and Cellular Biology 2005, 25:7796-7802.
63. Kalitsis P., Fowler K.J., Griffiths B., Earle E., Chow C.W., Jamsen K., et al. Increased chromosome instability but not cancer predisposition in haploinsufficient Bub3 mice. Genes, Chromosomes and Cancer 2005, 44:29-36.
64. Iwanaga Y., Chi Y.H., Miyazato A., Sheleg S., Haller K., Peloponese J.M., et al. Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Research 2007, 67:160-166.
65. Sotillo R., Schvartzman J.M., Socci N.D., Benezra R. Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 2010, 464:436-440.
66. Diaz-Rodríguez E., Sotillo R., Schvartzman J.M., Benezra R. Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:16719-16724.
67. Chesnokova V., Kovacs K., Castro A.V., Zonis S., Melmed S. Pituitary hypoplasia in Pttg-/- mice is protective for Rb+/- pituitary tumorigenesis. Molecular Endocrinology 2005, 19:2371-2379.
68. Wang Z., Yu R., Melmed S. Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Molecular Endocrinology 2001, 15:1870-1879.
69. Sussan T.E., Yang A., Li F., Ostrowski M.C., Reeves R.H. Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome. Nature 2008, 451:73-75.
70. Yang A., Reeves R.H. Increased survival following tumorigenesis in Ts65Dn mice that model Down syndrome. Cancer Research 2011, 71:3573-3581.
71. Dai W., Wang Q., Liu T., Swamy M., Fang Y., Xie S., et al. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Research 2004, 64:440-445.
72. Wang Q., Liu T., Fang Y., Xie S., Huang X., Mahmood R., et al. BUBR1 deficiency results in abnormal megakaryopoiesis. Blood 2004, 103:1278-1285.
73. Schvartzman J.M., Duijf P.H., Sotillo R., Coker C., Benezra R. Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 2011, 19:701-714.
74. Walther A., Houlston R., Tomlinson I. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 2008, 57:941-950.
75. Kronenwett U., Huwendiek S., Ostring C., Portwood N., Roblick U.J., Pawitan Y., et al. Improved grading of breast adenocarcinomas based on genomic instability. Cancer Research 2004, 64:904-909.
76. Carter S.L., Eklund A.C., Kohane I.S., Harris L.N., Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nature Genetics 2006, 38:1043-1048.
77. Swanton C., Nicke B., Schuett M., Eklund A.C., Ng C., Li Q., et al. Chromosomal instability determines taxane response. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:8671-8676.
78. Lagarde P., Pérot G., Kauffmann A., Brulard C., Dapremont V., Hostein I., et al. Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors. Clinical Cancer Research 2012, 18:826-838.
79. Birkbak N.J., Eklund A.C., Li Q., McClelland S.E., Endesfelder D., Tan P., et al. Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Research 2011, 71:3447-3452.
80. Roylance R., Endesfelder D., Gorman P., Burrell R.A., Sander J., Tomlinson I., et al. Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer. Cancer Epidemiology, Biomarkers and Prevention 2011, 20:2183-2194.
81. Duesberg P., Stindl R., Hehlmann R. Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:11283-11288.
82. Lee A.J., Endesfelder D., Rowan A.J., Walther A., Birkbak N.J., Futreal P.A., et al. Chromosomal instability confers intrinsic multidrug resistance. Cancer Research 2011, 71:1858-1870.
83. Yamada H.Y., Gorbsky G.J. Spindle checkpoint function and cellular sensitivity to antimitotic drugs. Molecular Cancer Therapeutics 2006, 5:2963-2969.
84. Baker D.J., Perez-Terzic C., Jin F., Pitel K.S., Pitel K., Niederländer N.J., et al. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nature Cell Biology 2008, 10:825-836.
85. Schliekelman M., Cowley D.O., O'Quinn R., Oliver T.G., Lu L., Salmon E.D., et al. Impaired Bub1 function in vivo compromises tension-dependent checkpoint function leading to aneuploidy and tumorigenesis. Cancer Research 2009, 69:45-54.
86. Sotillo R., Hernando E., Diaz-Rodriguez E., Teruya-Feldstein J., Cordon-Cardo C., Lowe S.W., et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007, 11:9-23.
87. Bagwell C.B., Clark G.M., Spyratos F., Chassevent A., Bendahl P.O., Stål O., et al. Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens. Cytometry 2001, 46:121-135.
88. Bauer H.C., Kreicbergs A., Tribukait B. DNA content prognostic in soft tissue sarcoma. 102 patients followed for 1-10 years. Acta Orthopaedica Scandinavica 1991, 62:187-194.
89. el-Naggar A.K., Ayala A.G., Abdul-Karim F.W., McLemore D., Ballance W.W., Garnsey L., et al. Synovial sarcoma. A DNA flow cytometric study. Cancer 1990, 65:2295-2300.
90. Nakazato Y., Minami Y., Kobayashi H., Satomi K., Anami Y., Tsuta K., et al. Nuclear grading of primary pulmonary adenocarcinomas: correlation between nuclear size and prognosis. Cancer 2010, 116:2011-2019.
91. Nakamura H., Saji H., Idiris A., Kawasaki N., Hosaka M., Ogata A., et al. Chromosomal instability detected by fluorescence in situ hybridization in surgical specimens of non-small cell lung cancer is associated with poor survival. Clinical Cancer Research 2003, 9:2294-2299.
92. Yoo J.W., Seo K.W., Jang S.J., Oh Y.M., Shim T.S., Kim W.S., et al. The relationship between the presence of chromosomal instability and prognosis of squamous cell carcinoma of the lung: fluorescence in situ hybridization analysis of paraffin-embedded tissue from 47 Korean patients. Journal of Korean Medical Science 2010, 25:863-867.
93. Mettu R.K., Wan Y.W., Habermann J.K., Ried T., Guo N.L. A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types. International Journal of Biological Markers 2010, 25:219-228.
94. Chibon F., Lagarde P., Salas S., Pérot G., Brouste V., Tirode F., et al. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nature Medicine 2010, 16:781-787.
95. Watanabe T., Kobunai T., Yamamoto Y., Matsuda K., Ishihara S., Nozawa K., et al. Chromosomal instability (CIN) phenotype, CIN high or CIN low, predicts survival for colorectal cancer. Journal of Clinical Oncology 2012, 30:2256-2264.